Julian R Reguero
Overview
Explore the profile of Julian R Reguero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
487
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coto E, Reguero J, Avanzas P, Pascual I, Martin M, Hevia S, et al.
Immunol Lett
. 2019 Mar;
208:39-43.
PMID: 30902734
The nuclear-factor kappa-beta (NF-KB) is a driver of inflammation, and plays an important role in the pathogenesis of atherosclerosis and coronary artery disease (CAD). Early-onset CAD is defined as a...
2.
Gomez J, Lorca R, Reguero J, Martin M, Moris C, Alonso B, et al.
Epigenomics
. 2018 Jul;
10(7):865-873.
PMID: 29962225
Aim: The long noncoding RNA H19 and its host micro RNA miR-675 have been found deregulated in cardiac hypertrophy and heart failure tissues. Our aim was to investigate whether the...
3.
Coto E, Corte C, Tranche S, Gomez J, Reguero J, Alonso B, et al.
DNA Cell Biol
. 2018 Jun;
37(7):617-625.
PMID: 29889555
The H19-IGF2 imprinted gene region could be implicated in the risk of developing impaired renal function (IRF). Our aim was to determine the association of several common H19-IGF2 variants and...
4.
Coto E, Diaz-Corte C, Tranche S, Gomez J, Alonso B, Iglesias S, et al.
Hum Immunol
. 2018 Mar;
79(6):494-498.
PMID: 29601852
The NF-kappaB pathway might play a role in the pathogenesis of renal disease and type 2 diabetes (T2DM). Our aim was to determine whether common polymorphisms in NF-kappaB genes were...
5.
Coto E, Calvo D, Reguero J, Moris C, Rubin J, Diaz-Corte C, et al.
Epigenomics
. 2017 Jul;
9(8):1049-1057.
PMID: 28749187
Aim: To investigate whether the differential methylation of KCNQ1OT1 was associated with the risk of symptomatic long QTc. Patients & Methods: We investigated the methylation status of KCNQ1OT1 in a...
6.
Gomez J, Lorca R, Reguero J, Moris C, Martin M, Tranche S, et al.
Circ Cardiovasc Genet
. 2017 Mar;
10(2).
PMID: 28356264
Background: Recent exome sequencing studies identified filamin C () as a candidate gene for hypertrophic cardiomyopathy (HCM). Our aim was to determine the rate of candidate variants in a large...
7.
Riobello C, Gomez J, Gil-Pena H, Tranche S, Reguero J, De la Hera J, et al.
Mol Cell Endocrinol
. 2016 Mar;
427:86-91.
PMID: 26970180
Several common KCNQ1 gene polymorphisms have been associated with the risk of type 2 diabetes (T2DM) and diabetic nephropathy. This effect is explained by the role of the kcnq1 protein...
8.
Gomez J, Reguero J, Junquera M, Alvarez C, Moris C, Alonso B, et al.
Int J Cardiol
. 2016 Feb;
209:149-50.
PMID: 26894465
No abstract available.
9.
Gomez J, Reguero J, Coto E
Rev Esp Cardiol (Engl Ed)
. 2015 Dec;
69(1):61-8.
PMID: 26654849
Massive DNA sequencing, also known as next-generation sequencing, has revolutionized genetic diagnosis. This technology has reduced the effort and cost needed to analyze several genes simultaneously and has made genetic...
10.
Gomez J, Reguero J, Alvarez C, Junquera M, Arango A, Moris C, et al.
Lung
. 2015 Apr;
193(4):571-4.
PMID: 25917481
The aim of this study was to characterize the mutational spectrum of pulmonary hypertension (PH) patients through a next generation sequencing platform. In a total of 22 patients, the BMPR2,...